These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25117462)

  • 21. Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART.
    Squillace N; Lorenzini P; Lapadula G; Bandera A; Cozzi-Lepri A; Rusconi S; Puoti M; Castagna A; Antinori A; Gori A; d'Arminio Monforte A;
    J Antimicrob Chemother; 2016 Sep; 71(9):2663-9. PubMed ID: 27272727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal fat depots, insulin resistance, and incident diabetes mellitus in women with and without HIV infection.
    Glesby MJ; Hanna DB; Hoover DR; Shi Q; Yin MT; Tien PC; Cohen M; Anastos K; Sharma A
    AIDS; 2018 Jul; 32(12):1643-1650. PubMed ID: 29794830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT; Ruppe MD; Kassner R; Kumar P; Kehoe T; Dobs AS; Timpone J
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.
    Gazzaruso C; Bruno R; Garzaniti A; Giordanetti S; Fratino P; Sacchi P; Filice G
    J Hypertens; 2003 Jul; 21(7):1377-82. PubMed ID: 12817187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
    Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
    J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
    Ledergerber B; Furrer H; Rickenbach M; Lehmann R; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Egger M; Weber R;
    Clin Infect Dis; 2007 Jul; 45(1):111-9. PubMed ID: 17554711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fish oil on lipid profile and other metabolic outcomes in HIV-infected patients on antiretroviral therapy: a randomized placebo-controlled trial.
    Oliveira JM; Rondó PH; Yudkin JS; Souza JM; Pereira TN; Catalani AW; Picone CM; Segurado AA
    Int J STD AIDS; 2014 Feb; 25(2):96-104. PubMed ID: 24285599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Overweight, obesity and underweight in HIV infected patients].
    Kwiatkowska W; Knysz B; Drelichowska-Durawa J; Czarnecki M; Gasiorowski J; Biłyk E; Karczewski M; Witkiewicz W
    Przegl Lek; 2013; 70(3):113-7. PubMed ID: 24003663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.
    Guaraldi G; Lonardo A; Ballestri S; Zona S; Stentarelli C; Orlando G; Carli F; Carulli L; Roverato A; Loria P
    Arch Med Res; 2011 Nov; 42(8):690-7. PubMed ID: 22227046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.
    Audelin AM; Lohse N; Obel N; Gerstoft J; Jørgensen LB
    Antivir Ther; 2009; 14(7):995-1000. PubMed ID: 19918103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults.
    Egaña-Gorroño L; Martínez E; Pérez I; Escribà T; Domingo P; Gatell JM; Arnedo M
    J Antimicrob Chemother; 2014 Nov; 69(11):3076-84. PubMed ID: 25185137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study.
    Squillace N; Lapadula G; Torti C; Orlando G; Mandalia S; Nardini G; Beghetto B; Costarelli S; Guaraldi G
    HIV Med; 2008 Mar; 9(3):151-9. PubMed ID: 18218000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy.
    Miller CD; El-Kholi R; Faragon JJ; Lodise TP
    Pharmacotherapy; 2007 Oct; 27(10):1379-86. PubMed ID: 17896893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Premature age-related comorbidities among HIV-infected persons compared with the general population.
    Guaraldi G; Orlando G; Zona S; Menozzi M; Carli F; Garlassi E; Berti A; Rossi E; Roverato A; Palella F
    Clin Infect Dis; 2011 Dec; 53(11):1120-6. PubMed ID: 21998278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of immunological and virological responses to antiretroviral therapy amongst HIV-infected adults in central Argentina: negative influence of hepatitis C infection.
    Farías AA; Kremer LE; Allende L; Díaz Mdel P; Pisano MB; Contigiani MS; Ré VE
    Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):432-7. PubMed ID: 23761392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and determinants of selected cardio-metabolic risk factors among people living with HIV/AIDS and receiving care in the South West Regional Hospitals of Cameroon: a cross-sectional study.
    Ngu RC; Choukem SP; Dimala CA; Ngu JN; Monekosso GL
    BMC Res Notes; 2018 May; 11(1):305. PubMed ID: 29769110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.